Marinomed Biotech AG Financials

Market Capitalization €49.59 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	5.58
Forward PE	6.75
Price to Sales TTM	€0.35
Price to Book MRQ	€0.52
Enterprise to Revenue	0.95
Enterprise to EBITDA	8.67

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	6.23%
Operating Margin	5.73%
Return on Assets TTM	2.66%
Return on Equity TTM	9.49%

Income Statement

Revenue TTM	€142,944,993,280
Revenue per Share TTM	€145.40
Quarterly Revenue Growth	-7.40%
Gross Profit TTM	€26,428,999,680
EBITDA	€20,209,000,000
Net Income to Common TTM	€8,910,999,552
Diluted EPS TTM	€9.07
Quarterly Earnings Growth YoY	-43.60%

Balance Sheet

Total Cash MRQ	€20,035,000,320
Total Cash per Share MRQ	€20.81
Total Debt MRQ	€
Total Debt to Equity MRQ	111.52
Current Ratio MRQ	1.34
Book Value per Share MRQ	€97.94

Cash Flow

Operating Cash Flow TTM	€19,136,999,424
Levered Free Cash Flow TTM	€6,662,750,208

MBG Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	962,903,703
Float Shares	623,439,234
Avg 10 Volume	6,508
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	19.83%
% Held by Institutions	33.41%

Stock Price Summary

Beta	0.92
Fifty Two Week Low	€44.80
Fifty Two Week High	€66.17
Fifty Two Week Change	-31.51%
Day 50 MA	€51.74
Day 200 MA	€54.77

Dividends and Splits

Forward Annual Dividend Rate	€21.20
Forward Annual Dividend Yield	42.46%
Trailing Annual Dividend Rate	€5.30
Trailing Annual Dividend Yield	10.61%
Payout Ratio	58.43%
Dividend Date
Ex Dividend Date	2025-05-08
Last Split Factor
Last Split Date